A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4745 (2006.01) A61K 31/09 (2006.01) A61K 31/135 (2006.01) A61K 31/138 (2006.01) A61K 31/47 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2470484
An antitumor combination comprising a stilbene derivative and an anticancer compound selected from the group consisting of taxanes, alkylating agents, antimetabolites, vinca alkaloids, epidophylloptoxins, and antibiotics as the active ingredients is provided. There are also provided methods of using these pharmaceutical preparations for the treatment of solid carcinomas and the like.
L'invention concerne une combinaison antitumorale comprenant un dérivé de stilbène et un composé anticancéreux choisi dans le groupe comprenant les taxanes, les agents d'alkylation, les antimétabolites, les alcaloïdes de la pervenche, les épidophylloptoxines et les antibiotiques comme ingrédients actifs. L'invention concerne également des procédés d'utilisation de ces préparations pharmaceutiques pour traiter des carcinomes solides et similaires.
Aventis Pharma S.a.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
A combination comprising combretastatin and anticancer agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A combination comprising combretastatin and anticancer agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A combination comprising combretastatin and anticancer agents will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2089330